Globus Medical Announces FDA 510(k) Clearance for Excelsius GPS™
Globus Medical Announces FDA 510(k) Clearance for Excelsius GPS™ AUDUBON, Pa., Aug. 17, 2017 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that the Excelsius GPS™, a revolutionary robotic guidance and navigation READ MORE